Organon & Co | OGN - Resultado Líquido





Resultado Líquido Alterar Data
Bristol-Myers Squibb USD 2.16B 1.16B 2026-09
Celltrion KRW 13.72B 4.9B 2026-06
Cspc Pharmaceutical CNY 370.72M 592.81M 2025-12
Deva Holding AS TRY 583.98M 319.1M 2023-09
Dianthus Therapeutics USD -50.22M 9.38M 2026-06
Divis Laboratories Ltd INR 11.27B 2.25B 2026-09
Gilead Sciences USD -10.5B 12.52B 2026-06
Glaxosmithkline GBP 1.54B 194M 2026-09
Kangmei Pharma CNY 52.6M 69.16M 2026-06
Knight Therapeutics CAD -3.79M 8.83M 2025-09
Laboratorios Farma EUR 103.69M 37.04M 2023-12
Malin Corporation EUR -1.1M 2.2M 2023-12
Medical Developments International AUD -226K 121K 2025-12
Merck USD 5.07B 6.4B 2026-09
Neuren Pharmaceuticals AUD 15.4M 7.88M 2025-12
Novartis USD 1.2B 1.95B 2026-09
Organigram Holdings CAD 105.54M 106.46M 2026-06
Organon & Co USD 164M 56M 2026-09
Ovoca Bio EUR 4.42M 5.19M 2025-12
Pharma Mar EUR 8.14M 9.12M 2026-09
Qiagen NV USD 103.4M 35.36M 2026-06
Sartorius EUR 66.1M 200K 2026-09
Sino Biopharmaceutical CNY 3.39B 2.91B 2025-06
Tilray USD -44.93M 44.61M 2025-09
Zealand Pharma A/S -394M 14.88M 2026-03